DESANTIS CARL 4
Research Summary
AI-generated summary
Integrated Biopharma (INBP) 10% Owner Carl DeSantis Gifts 11.2M Shares
What Happened
- Carl DeSantis (reported as a 10% owner) transferred a total of 11,201,964 shares of Integrated Biopharma, Inc. (INBP) as gifts on April 15, 2026. The transfers were reported as two gift transactions: 8,966,547 shares and 2,235,417 shares. Each transaction shows a price of $0.00, so there were no sale proceeds reported.
Key Details
- Transaction date: April 15, 2026; Form 4 filed April 17, 2026 (within normal 2-business-day reporting window).
- Shares transferred: 8,966,547 (footnote F1) and 2,235,417 (footnote F2); total = 11,201,964 shares.
- Price/consideration: $0.00 (gift); reported total value $0.
- Footnotes: F1 — 8,966,547 shares moved from CD Financial, LLC to CDDS 2.0, LLC (a Florida LLC controlled by Damon DeSantis). F2 — 2,235,417 shares moved from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC (controlled by Damon DeSantis).
- Shares owned after transaction: not specified in the provided filing excerpt.
Context
- Gifts are dispositions for reporting purposes but do not represent a market sale or necessarily signal the insider’s view of the company’s prospects. These transfers appear to be internal/related-party movements to an entity controlled by Damon DeSantis.
- As a 10% owner (not an executive transaction), this is institutional/owner-level reorganization rather than routine open-market trading.